Costs for Hospital Treatment of Surgical Vascular Diseases (by the Example of the Moscow Region)

The objective is to compare the average cost of inpatient treatment of vascular diseases requiring surgery included and not included in the list of diseases requiring high-tech medical treatment (HMT).

Methods.

“Incomplete inpatient treatment cases” in the terminology of health insurance were analyzed, the first stage of emergency or planned medical care in the later stages of vascular diseases. We used data of the impersonal register of deaths from Rosstat and impersonal database of Moscow region compulsory health insurance fund for 2014. In medicalorganizations of different levels, indicators for vascular diseasesrequiring surgery included in theHMT program (group 1) and diseases not included in theHMT program (group 2) were compared.

Results.

Among theincomplete inpatient treatment cases of vascular diseases requiring surgery the 1^st group disease was 4,9%, of which 64,3 % was treated in hospitals of the third level and 18,6% in hospitals of the first level. In medicalorganizations of the first and second levels the cost of treatment of vascular diseases requiring surgery of group 2 is significantly greater than the cost of treatment of group 1.

Conclusions.

Late diagnosis of vascular diseases requiring surgery leads to the increased costs of compulsory medical insurance.

The inclusion of vascular diseases requiring surgery to a high-tech medical treatment program improves the quality of medical care.

The high-tech medical treatment program must be supplemented with atherosclerosis of the arteries of limbs (I70.2,), embolism and thrombosis of arteries (I74) which will significantly reduce mortality from these diseases.